Dana M, Louppe C, Koskas Y, Chotin G, Briot E
J Radiol Electrol Med Nucl. 1977 May;58(5):365-70.
The moving Strip Technique for irradiation of the abdomen perfected by Fletcher and Delclos represents considerable progress in terms of radiotherapy for carcinomas of the ovary by virtue of its simplicity, good tolerance, the homogeneous dose delivered to the entire abdominal cavity and the absence of sequelae. It is possible to deliver a dose of the order of 2.500 rads in 10 days to each abdominal segment, this being equivalent of 3,500 rads in 3,5 weeks. This moderate dose is aimed only at dealing with micronodular invasion and the superimposition of added local doses is required for residual tumour, marked using clips. Of 18 cases treated, including. 15 et stages III and IV, overall survival at 4 years is 52.5%. Two patients at stage III survived for more than 2 years with radiotherapy alone, whilst all at stages I and II are still alive. Have survived for more than two years with radiotherapy alone, whilst all at stages I and II are still alive. From a histological standpoint, the worst group seems to be adenocarcinomas (all dead). Systematic sequential surgery for excision or reduction, chemotherapy to dry out ascites, moving strip irradiation with superimposed doses locally and long term chemotherapy should make it possible to improve the prognostic results of this tumour, for which the outlook remains poor.
由弗莱彻和德尔克洛斯完善的腹部移动条带照射技术，因其操作简单、耐受性良好、能向整个腹腔均匀输送剂量且无后遗症，在卵巢癌放射治疗方面代表了相当大的进步。在10天内可向每个腹部节段输送约2500拉德的剂量，这相当于在3.5周内输送3500拉德。这种适度剂量仅旨在处理微小瘤结节浸润，对于残留肿瘤（用夹子标记）则需要叠加额外的局部剂量。在治疗的18例患者中，包括15例III期和IV期患者，4年总生存率为52.5%。两名III期患者仅通过放疗存活超过2年，而所有I期和II期患者仍存活。仅通过放疗存活超过两年，而所有I期和II期患者仍存活。从组织学角度来看，最差的组似乎是腺癌（全部死亡）。系统性的序贯手术切除或减瘤、使腹水干涸的化疗、局部叠加剂量的移动条带照射以及长期化疗，应该能够改善这种肿瘤的预后结果，目前其预后仍然很差。
